| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.089 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |